To identify whether GRAMD4‐mediated downregulation of TAK1 was responsible for its anti‐tumour effects, GRAMD4‐knockdown Hep3B cells were transfected with an siRNA against TAK1. This evidence concerns the gene GRAMD4 and neoplasm.